The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1995-04, Vol.38 (8), p.1255-1258
Hauptverfasser: Koch, Kevin, Newborg, Michael F, Hanson, Douglas C, Cooper, Kelvin, Shepard, Richard M, Biehl, Michael L, Biggers, Michael S, Ramchandani, Mukesh, Schulte, Gary
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1258
container_issue 8
container_start_page 1255
container_title Journal of medicinal chemistry
container_volume 38
creator Koch, Kevin
Newborg, Michael F
Hanson, Douglas C
Cooper, Kelvin
Shepard, Richard M
Biehl, Michael L
Biggers, Michael S
Ramchandani, Mukesh
Schulte, Gary
description
doi_str_mv 10.1021/jm00008a001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77242347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77242347</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-f946376eacda34932ccb8f02aec8012a394444c2df45333c8a2cfaa7bbcdd72c3</originalsourceid><addsrcrecordid>eNpt0E1vEzEQBmALgUoonDgj-YDgUBZsj3e94RaFthQFNajL2ZrMetUN-xFsb0X-PYZEEQfmMod59Gr0MvZSivdSKPlh24s0JQohH7GZzJXIdCn0YzYTQqlMFQqesmchbJMCqeCMnZkcDICcsb66d3yZgeKVb5Fc3HfZKvP32A9jcPyT8-0DxvbB8bHhi0Bjv6d2-MgXfD1GN8R3_NZj1-35gv6qr0h-7JDiODh-0_dTipl2O-9CwCE-Z08a7IJ7cdzn7PvVZbX8nK1ur2-Wi1WGUELMmrkuwBQOqUbQc1BEm7IRCh2VQiqEuU5Dqm50DgBUoqIG0Ww2VNdGEZyzN4fcnR9_Ti5E27eBXNfh4MYpWGOUVqBNghcHmL4OwbvG7nzbo99bKeyfcu0_5Sb96hg7bXpXn-yxzXR_fbxjIOwajwO14cQgl0YXeWLZgbUhul-nM_oftjBgclut7-z6-q401dUX-y35twePFOx2nPyQuvvvg78BF_SdSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77242347</pqid></control><display><type>article</type><title>The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Koch, Kevin ; Newborg, Michael F ; Hanson, Douglas C ; Cooper, Kelvin ; Shepard, Richard M ; Biehl, Michael L ; Biggers, Michael S ; Ramchandani, Mukesh ; Schulte, Gary</creator><creatorcontrib>Koch, Kevin ; Newborg, Michael F ; Hanson, Douglas C ; Cooper, Kelvin ; Shepard, Richard M ; Biehl, Michael L ; Biggers, Michael S ; Ramchandani, Mukesh ; Schulte, Gary</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00008a001</identifier><identifier>PMID: 7537331</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Administration, Oral ; Animals ; Biological and medical sciences ; Carbohydrate Sequence ; Humans ; Immunomodulators ; Immunosuppressive Agents - administration &amp; dosage ; Immunosuppressive Agents - chemistry ; Immunosuppressive Agents - pharmacology ; Lactones - chemistry ; Medical sciences ; Molecular Sequence Data ; Pharmacology. Drug treatments ; Rats ; Rhamnose - chemistry ; Tacrolimus - administration &amp; dosage ; Tacrolimus - analogs &amp; derivatives ; Tacrolimus - chemistry ; Tacrolimus - pharmacology</subject><ispartof>Journal of medicinal chemistry, 1995-04, Vol.38 (8), p.1255-1258</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a383t-f946376eacda34932ccb8f02aec8012a394444c2df45333c8a2cfaa7bbcdd72c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00008a001$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00008a001$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27074,27922,27923,56736,56786</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3517465$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7537331$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koch, Kevin</creatorcontrib><creatorcontrib>Newborg, Michael F</creatorcontrib><creatorcontrib>Hanson, Douglas C</creatorcontrib><creatorcontrib>Cooper, Kelvin</creatorcontrib><creatorcontrib>Shepard, Richard M</creatorcontrib><creatorcontrib>Biehl, Michael L</creatorcontrib><creatorcontrib>Biggers, Michael S</creatorcontrib><creatorcontrib>Ramchandani, Mukesh</creatorcontrib><creatorcontrib>Schulte, Gary</creatorcontrib><title>The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><subject>Administration, Oral</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carbohydrate Sequence</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunosuppressive Agents - chemistry</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Lactones - chemistry</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rhamnose - chemistry</subject><subject>Tacrolimus - administration &amp; dosage</subject><subject>Tacrolimus - analogs &amp; derivatives</subject><subject>Tacrolimus - chemistry</subject><subject>Tacrolimus - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0E1vEzEQBmALgUoonDgj-YDgUBZsj3e94RaFthQFNajL2ZrMetUN-xFsb0X-PYZEEQfmMod59Gr0MvZSivdSKPlh24s0JQohH7GZzJXIdCn0YzYTQqlMFQqesmchbJMCqeCMnZkcDICcsb66d3yZgeKVb5Fc3HfZKvP32A9jcPyT8-0DxvbB8bHhi0Bjv6d2-MgXfD1GN8R3_NZj1-35gv6qr0h-7JDiODh-0_dTipl2O-9CwCE-Z08a7IJ7cdzn7PvVZbX8nK1ur2-Wi1WGUELMmrkuwBQOqUbQc1BEm7IRCh2VQiqEuU5Dqm50DgBUoqIG0Ww2VNdGEZyzN4fcnR9_Ti5E27eBXNfh4MYpWGOUVqBNghcHmL4OwbvG7nzbo99bKeyfcu0_5Sb96hg7bXpXn-yxzXR_fbxjIOwajwO14cQgl0YXeWLZgbUhul-nM_oftjBgclut7-z6-q401dUX-y35twePFOx2nPyQuvvvg78BF_SdSQ</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>Koch, Kevin</creator><creator>Newborg, Michael F</creator><creator>Hanson, Douglas C</creator><creator>Cooper, Kelvin</creator><creator>Shepard, Richard M</creator><creator>Biehl, Michael L</creator><creator>Biggers, Michael S</creator><creator>Ramchandani, Mukesh</creator><creator>Schulte, Gary</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950401</creationdate><title>The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant</title><author>Koch, Kevin ; Newborg, Michael F ; Hanson, Douglas C ; Cooper, Kelvin ; Shepard, Richard M ; Biehl, Michael L ; Biggers, Michael S ; Ramchandani, Mukesh ; Schulte, Gary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-f946376eacda34932ccb8f02aec8012a394444c2df45333c8a2cfaa7bbcdd72c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carbohydrate Sequence</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunosuppressive Agents - chemistry</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Lactones - chemistry</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rhamnose - chemistry</topic><topic>Tacrolimus - administration &amp; dosage</topic><topic>Tacrolimus - analogs &amp; derivatives</topic><topic>Tacrolimus - chemistry</topic><topic>Tacrolimus - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koch, Kevin</creatorcontrib><creatorcontrib>Newborg, Michael F</creatorcontrib><creatorcontrib>Hanson, Douglas C</creatorcontrib><creatorcontrib>Cooper, Kelvin</creatorcontrib><creatorcontrib>Shepard, Richard M</creatorcontrib><creatorcontrib>Biehl, Michael L</creatorcontrib><creatorcontrib>Biggers, Michael S</creatorcontrib><creatorcontrib>Ramchandani, Mukesh</creatorcontrib><creatorcontrib>Schulte, Gary</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koch, Kevin</au><au>Newborg, Michael F</au><au>Hanson, Douglas C</au><au>Cooper, Kelvin</au><au>Shepard, Richard M</au><au>Biehl, Michael L</au><au>Biggers, Michael S</au><au>Ramchandani, Mukesh</au><au>Schulte, Gary</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>38</volume><issue>8</issue><spage>1255</spage><epage>1258</epage><pages>1255-1258</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>7537331</pmid><doi>10.1021/jm00008a001</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1995-04, Vol.38 (8), p.1255-1258
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_77242347
source MEDLINE; American Chemical Society Journals
subjects Administration, Oral
Animals
Biological and medical sciences
Carbohydrate Sequence
Humans
Immunomodulators
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - chemistry
Immunosuppressive Agents - pharmacology
Lactones - chemistry
Medical sciences
Molecular Sequence Data
Pharmacology. Drug treatments
Rats
Rhamnose - chemistry
Tacrolimus - administration & dosage
Tacrolimus - analogs & derivatives
Tacrolimus - chemistry
Tacrolimus - pharmacology
title The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A12%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20C-32%20Triacetyl-L-rhamnose%20Derivative%20of%20Ascomycin:%20A%20Potent,%20Orally%20Active%20Macrolactone%20Immunosuppressant&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Koch,%20Kevin&rft.date=1995-04-01&rft.volume=38&rft.issue=8&rft.spage=1255&rft.epage=1258&rft.pages=1255-1258&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00008a001&rft_dat=%3Cproquest_cross%3E77242347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77242347&rft_id=info:pmid/7537331&rfr_iscdi=true